Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of nalbuphine and fentanyl on postoperative nausea and vomiting in laparoscopic cholecystectomy
TCTR20250526001Phase 2Recruiting
- Sponsor
- Thammasat University
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nalbuphine and fentanyl in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Thammasat University. Primary endpoint: Postoperative nausea and vomiting incidence. Started Jan 2025; status: recruiting.
02
Drugs
nalbuphinefentanyl
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on TCTR20250526001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250526001.